EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 70 / Numéro 2 (Mars-Avril 2015) Therapie, 70 2 (2015) 141-146 Références
Numéro
Therapie
Volume 70, Numéro 2, Mars-Avril 2015
Addictovigilance : le défi pharmacologique de l'évaluation et de la prévention des substances à risque
Page(s) 141 - 146
Section Addictovigilance / Addictovigilance
DOI https://doi.org/10.2515/therapie/2014223
Publié en ligne 9 avril 2015
  1. Ross S, Peselow E. The neurobiology of addictive disorders. Clin Neuropharmacol 2009; 32 : 269-76 [CrossRef] [PubMed] [Google Scholar]
  2. George O, Le Moal M, Koob GF. Allostatis and addiction: role of dopamine and corticotrophin-releasing factor systems. Physiol Behav 2012; 106: 58-64 [CrossRef] [PubMed] [Google Scholar]
  3. Mameli M, Lüscher C. Synaptic plasticity and addiction: learning mechanisms gone awry. Neuropharmacology 2011; 61: 1052-9 [CrossRef] [PubMed] [Google Scholar]
  4. Stolberg VB. The use of coca: prehistory, history, and ethnography. J Ethn Subst Abuse 2011; 10: 126-46 [CrossRef] [PubMed] [Google Scholar]
  5. Nichols DE. Hallucinogens. Pharmacol Ther 2004; 101: 131-81 [CrossRef] [PubMed] [Google Scholar]
  6. Lingford-Hughes A, Watson B, Kalk N, et al. Neuropharmacology of addiction and how it informs treatment. Br Med Bull 2010; 96: 93-110 [CrossRef] [PubMed] [Google Scholar]
  7. Way EL. History of opiate use in the Orient and the United States. Ann N Y Acad Sci 1982; 398: 12-23 [CrossRef] [PubMed] [Google Scholar]
  8. Wood S, Sage JR, Shuman T, et al. Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev 2013; 66: 193-221 [CrossRef] [PubMed] [Google Scholar]
  9. Bernschneider-Reif S, Oxler F, Freudenmann RW. The origin of MDMA (“ecstasy”)–separating the facts from the myth. Pharmazie 2006; 61: 966-72 [PubMed] [Google Scholar]
  10. Ban TA. The role of serendipity in drug discovery. Dialogues Clin Neurosci 2006; 8: 335-44 [PubMed] [Google Scholar]
  11. Lopez-Munoz F, Alamo C, García-García P. The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs. J Anxiety Disord 2011; 25: 554-62 [CrossRef] [PubMed] [Google Scholar]
  12. Berridge KC, Robinson TE, Aldridge JW. Dissecting components of reward: “liking”, “wanting”, and learning. Curr Opin Pharmacol 2009; 9 : 65-73 [CrossRef] [PubMed] [Google Scholar]
  13. Aguilar MA, Rodríguez-Arias M, Miñarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 2009; 59 : 253-77 [CrossRef] [PubMed] [Google Scholar]
  14. Cui C, Noronha A, Morikawa H, et al. New insights on neurobiological mechanisms underlying addiction. Neuropharmacology 2013; 67: 223-32 [CrossRef] [PubMed] [Google Scholar]
  15. Bossert JM, Marchant NJ, Calu DJ, et al. The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology 2013; 229: 453-76 [CrossRef] [PubMed] [Google Scholar]
  16. Rømer Thomsen K, Fjordback LO, Moller A, et al. Applying incentive sensitization models to behavioral addiction. Neurosci Biobehav Rev 2014 Sep; 45: 349-9 [Google Scholar]
  17. Steketee JD, Kalivas PW. Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 2011; 63: 348-65 [CrossRef] [PubMed] [Google Scholar]
  18. Leyton M, Vezina P. Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model. Trends Pharmacol Sci 2014; 35: 268-76 [CrossRef] [PubMed] [Google Scholar]
  19. George O, Le Moal M, Koob GF. Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems. Physiol Behav 2012; 106: 58-64 [CrossRef] [PubMed] [Google Scholar]
  20. Fernando ABP, Robbins TW. Animal models of neuropsychiatric disorders. Annu Rev Clin Psychol 2011; 7: 39-61 [CrossRef] [PubMed] [Google Scholar]
  21. Ahmed SH. The science of making drug-addicted animals. Neuroscience 2012; 211: 107-25 [CrossRef] [PubMed] [Google Scholar]
  22. Fowler CD, Kenny PJ. Utility of genetically modified mice for understanding the neurobiology of substance use disorders. Hum Genet 2012; 131: 941-57 [CrossRef] [PubMed] [Google Scholar]
  23. Søvik E, Barron AB. Invertebrate models in addiction research. Brain Behav Evol 2013; 82: 153-65 [CrossRef] [PubMed] [Google Scholar]
  24. Hopf FW, Lesscher HMB. Rodent models for compulsive alcohol intake. Alcohol 2014; 48: 253-64 [CrossRef] [PubMed] [Google Scholar]
  25. Marchant NJ, Li X, Shaham Y. Recent developments in animal models of drug relapse. Curr Opin Neurobiol 2013; 23: 675-83 [CrossRef] [PubMed] [Google Scholar]
  26. Skinner MD, Aubin HJ. Craving’s place in addiction theory: contributions of the major models. Neurosci Biobehav Rev 2010; 34: 606-23 [CrossRef] [PubMed] [Google Scholar]
  27. Perry CJ, Zbukvic I, Kim JH, et al. Role of cues and contexts on drug-seeking behavior. Br J Pharmacol 2014 oct; 171(20): 4636-72 [CrossRef] [PubMed] [Google Scholar]
  28. Izquierdo A, Jentsch JD. Reversal learning as a measure of impulsive and compulsive behavior in addictions. Psychopharmacology 2012; 219: 607-20 [CrossRef] [PubMed] [Google Scholar]
  29. Robinson MJF, Berridge KC. Instant transformation of learned repulsion into motivational “wanting”. Curr Biol 2013; 23: 282-9 [Google Scholar]
  30. Feil J, Sheppard D, Fitzgerald PB, et al. Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev 2010; 35: 248-75 [CrossRef] [PubMed] [Google Scholar]
  31. Linnet J. Neurobiological underpinnings of reward anticipation and outcome evaluation in gambling disorder. Front Behav Neurosci 2014; 8: 100 [CrossRef] [PubMed] [Google Scholar]
  32. Tassin JP. Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse. Biochem Pharmacol 2008; 75: 85-97 [CrossRef] [PubMed] [Google Scholar]
  33. Ducci F, Goldman D. The genetic basis of addictive disorders. Psychiatr Clin North Am 2012; 35: 495-519 [CrossRef] [PubMed] [Google Scholar]
  34. Enoch MA. The influence of gene-environment interactions on the development of alcoholism and drug dependence. Curr Psychiatry Rep 2012; 14(2): 150-8 [CrossRef] [PubMed] [Google Scholar]
  35. Vassoler FM, Byrnes EM, Pierce RC. The impact of exposure to addictive drugs on future generations: physiological and behavioral effects. Neuropharmacology 2014; 76: 269-75 [CrossRef] [PubMed] [Google Scholar]
  36. Vassoler FM, Sadri-Vakili G. Mechanisms of transgenerational inheritance of addictive-like behaviors. Neuroscience 2014; 264: 198-206 [CrossRef] [PubMed] [Google Scholar]
  37. Sjoerds Z, Luigjes J, Van Den Brink W, et al. The role of habits and motivation in human drug addiction: a reflection. Front Psychiatry 2014; 5: 8 [CrossRef] [PubMed] [Google Scholar]
  38. Kennett J, Matthews S, Snoek A. Pleasure and addiction. Front Psychiatry 2013; 4: 117 [CrossRef] [PubMed] [Google Scholar]
  39. Flanagan O. The shame of addiction. Front Psychiatry 2013; 4: 120 [CrossRef] [PubMed] [Google Scholar]
  40. Strang J, Babor T, Caulkins J, et al. Drug policy and the public good: evidence for effective interventions. Lancet 2012; 379: 71-83 [CrossRef] [PubMed] [Google Scholar]